Alterity Therapeutics Ltd (PRNAF) SEC Filings — 2025
50 SEC filings for Alterity Therapeutics Ltd (PRNAF) in 2025.
Filings
- Alterity Therapeutics Files 6-K, Incorporates Director's Interest Notice — 6-K · Nov 24, 2025
- Alterity Therapeutics Ltd 6-K Filing — 6-K · Nov 21, 2025
- Alterity Therapeutics Ltd 6-K Filing — 6-K · Nov 13, 2025
- Alterity Therapeutics to Present at Bell Conference — 6-K · Nov 12, 2025
- Alterity Therapeutics Ltd 6-K Filing — 6-K · Nov 10, 2025
- Alterity Therapeutics Files 6-K, Incorporates Activities Report — 6-K · Oct 31, 2025
- Alterity Therapeutics Files 6-K for AGM Notice — 6-K · Oct 21, 2025
- Alterity Therapeutics Files 6-K on Holding Change — 6-K · Oct 15, 2025
- Alterity Therapeutics Presents Positive ATH434 Data — 6-K · Oct 9, 2025
- Alterity Therapeutics Files 6-K, Incorporates Presentations — 6-K · Oct 2, 2025
- Alterity Therapeutics Ltd. Announces AGM Date — 6-K · Sep 23, 2025
- Alterity Therapeutics Files 6-K on Substantial Holding Change — 6-K · Sep 17, 2025
- Alterity Therapeutics Files 6-K, Incorporates by Reference — 6-K · Sep 15, 2025
- Alterity Therapeutics Raises $20M in Strategic Placement — 6-K · Sep 8, 2025
- Alterity Therapeutics Trading Halt for Capital Raise — 6-K · Sep 4, 2025
- Alterity Therapeutics Files 6-K, Incorporates into S-8/F-3 Filings — 6-K · Sep 2, 2025
- Alterity Secures Funding Amidst Persistent R&D Losses — 20-F · Aug 29, 2025
- Alterity Therapeutics Files 6-K, Incorporates into Registration Statements — 6-K · Aug 22, 2025
- Alterity Therapeutics Files 6-K on Unquoted Securities — 6-K · Aug 15, 2025
- Alterity Therapeutics Files 6-K, Incorporates by Reference — 6-K · Aug 4, 2025
- Alterity Therapeutics Files 6-K with Updated Corporate Presentation — 6-K · Jul 31, 2025
- Alterity Therapeutics Files 6-K, Incorporates Cash Flow Report — 6-K · Jul 30, 2025
- Alterity Therapeutics Files 6-K on Substantial Holding Change — 6-K · Jul 28, 2025
- Alterity Therapeutics Files 6-K with BioMUSE Study Publication — 6-K · Jul 24, 2025
- Alterity Therapeutics Files 6-K, Incorporates into Registration Statements — 6-K · Jul 21, 2025
- Alterity Therapeutics Files 6-K, Incorporates into Registrations — 6-K · Jul 17, 2025
- Alterity Therapeutics Files 6-K with ASX Price Query Response — 6-K · Jul 14, 2025
- Alterity Therapeutics Files 6-K on Substantial Holding Change — 6-K · Jul 7, 2025
- Alterity Therapeutics Files 6-K, Incorporates by Reference — 6-K · Jul 3, 2025
- Alterity Therapeutics Files 6-K on Security Cessation — 6-K · Jun 30, 2025
- Alterity Therapeutics CEO to Update on ATH434 — 6-K · Jun 23, 2025
- Alterity Therapeutics Files 6-K on Shareholder Holdings — 6-K · May 23, 2025
- Alterity Therapeutics Featured at International MSA Congress — 6-K · May 12, 2025
- Alterity Therapeutics to Present Phase 2 Data at MSA Congress — 6-K · May 7, 2025
- Alterity Therapeutics Gets FDA Fast Track for ATH434 — 6-K · May 5, 2025
- Alterity Therapeutics Files 6-K, Incorporates Cash Flow Report — 6-K · Apr 30, 2025
- Alterity Therapeutics Files 6-K on Director Interest Change — 6-K · Apr 29, 2025
- Alterity Therapeutics Files 6-K, Includes Phase 2 Presentation — 6-K · Apr 28, 2025
- Alterity Therapeutics Files Updated Corporate Presentation — 6-K · Apr 22, 2025
- Alterity Therapeutics Files 6-K with Options Prospectus — 6-K · Apr 17, 2025
- Alterity Therapeutics Files Director Interest Notice — 6-K · Apr 10, 2025
- Alterity Therapeutics Files 6-K, Incorporates by Reference — 6-K · Apr 9, 2025
- Alterity Therapeutics Files 6-K on Substantial Holding Change — 6-K · Apr 8, 2025
- Alterity Therapeutics Files 6-K, Incorporates into Registrations — 6-K · Apr 7, 2025
- Alterity Therapeutics to Present ATH434 Trial Data at AAN — 6-K · Apr 3, 2025
- Alterity Therapeutics Files 6-K with Meeting Results — 6-K · Mar 31, 2025
- Alterity Therapeutics Completes Last Patient Visit in Open-Label Trial — 6-K · Mar 27, 2025
- Alterity Therapeutics Files 6-K, Reports Substantial Holder Change — 6-K · Mar 25, 2025
- Alterity Therapeutics Files 6-K, Incorporates into Registrations — 6-K · Mar 14, 2025
- Alterity Therapeutics Files 6-K, Incorporates into Registrations — 6-K · Mar 14, 2025